About Apella
Apella is a company based in San Francisco (United States) founded in 2021 by Jordan Tuttle and Cameron Marlow. It operates as a AI-as-a-Service, and HealthTech. Apella has raised $101 million across 2 funding rounds from investors including Casdin Capital, Vensana Capital and PFM Health Sciences. The company has 34 employees as of December 31, 2022. Apella offers products and services including Apella Horizon. Apella operates in a competitive market with competitors including Caresyntax, ClearPoint Neuro, Cydar Medical, Perfint Healthcare and MediView, among others.
- Headquarter San Francisco, United States
- Employees 34 as on 31 Dec, 2022
- Founders Jordan Tuttle, Cameron Marlow
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$101 M (USD)
in 2 rounds
-
Latest Funding Round
$80 M (USD), Series B
Jan 08, 2026
-
Investors
Casdin Capital
& 9 more
-
Employee Count
34
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Apella
Apella offers a comprehensive portfolio of products and services, including Apella Horizon. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-powered platform optimizing surgical schedules and capacity.
Unlock access to complete
Funding Insights of Apella
Apella has successfully raised a total of $101M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $80 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $80.0M
-
First Round
First Round
(20 Dec 2021)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Series B - Apella | Valuation | HighlandX | |
| Dec, 2021 | Amount | Series A - Apella | Valuation | Casdin Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Apella
Apella has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Casdin Capital, Vensana Capital and PFM Health Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Investments in medical technology are made by Vensana Capital.
|
Founded Year | Domain | Location | |
|
Healthcare companies are invested in by this private equity firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Apella
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Apella
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Apella Comparisons
Competitors of Apella
Apella operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Caresyntax, ClearPoint Neuro, Cydar Medical, Perfint Healthcare and MediView, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Surgical outcomes are enhanced via analytics and integration platform.
|
|
| domain | founded_year | HQ Location |
Software and hardware solutions for MRI-guided surgical planning are provided.
|
|
| domain | founded_year | HQ Location |
Surgical images are analyzed via AI for endovascular procedures.
|
|
| domain | founded_year | HQ Location |
Solutions for image-guided interventional procedures are developed.
|
|
| domain | founded_year | HQ Location |
Digital medical images are managed for healthcare providers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Apella
When was Apella founded?
Apella was founded in 2021.
Where is Apella located?
Apella is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Apella a funded company?
Apella is a funded company, having raised a total of $101M across 2 funding rounds to date. The company's 1st funding round was a Series A of $21M, raised on Dec 20, 2021.
How many employees does Apella have?
As of Dec 31, 2022, the latest employee count at Apella is 34.
What does Apella do?
Apella is engaged in providing AI-driven solutions for operating room optimization within the healthcare sector. The platform integrates with electronic health records to deliver real-time data and analytics, enabling surgical teams to enhance scheduling, reduce delays, and increase capacity. Solutions are designed to improve workflow efficiency, automate administrative tasks, and support better patient care outcomes through data-driven insights and predictive scheduling tools.
Who are the top competitors of Apella?
Apella's top competitors include Caresyntax, ClearPoint Neuro and VitVio.
What products or services does Apella offer?
Apella offers Apella Horizon.
Who are Apella's investors?
Apella has 10 investors. Key investors include Casdin Capital, Vensana Capital, PFM Health Sciences, Twine Ventures, and Upside Partnership.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.